ConductScience.org, home

Paper39138705

E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.

Taha SR and 1 other. Histopathology, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes. Papers, record 39138705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39138705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.
PubMed
Journal
Histopathology
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.37, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Taha SRSeyed Rhttps://orcid.org/0000-0001-7413-1810
2Boulos FFouadhttps://orcid.org/0000-0003-1921-081X

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
CadherinsMajor topic
Carcinoma, Ductal, BreastMajor topic
Carcinoma, LobularMajor topic
Female
Humans
Immunohistochemistry
Antigens, CD

Source PubMed

Download CSV of topics

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136482279Update on lobular lesions of the breast.Histopathology2023https://conductscience.org/library/papers/36482279PubMed
27534041Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.Am J Pathol1995https://conductscience.org/library/papers/7534041PubMed
337537585Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.Cell Commun Signal2023https://conductscience.org/library/papers/37537585PubMed
48197774Evaluation and management of high risk and premalignant lesions of the breast.World J Surg1994https://conductscience.org/library/papers/8197774PubMed
528190105EMT promoting transcription factors as prognostic markers in human breast cancer.Arch Gynecol Obstet2017https://conductscience.org/library/papers/28190105PubMed
616230078Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats.Gastroenterology2005https://conductscience.org/library/papers/16230078PubMed
717097565Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.Cancer Cell2006https://conductscience.org/library/papers/17097565PubMed
819789364Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.Cancer Epidemiol Biomarkers Prev2009https://conductscience.org/library/papers/19789364PubMed
919403558The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.Hum Mol Genet2009https://conductscience.org/library/papers/19403558PubMed
1027073531CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer.Oncol Lett2016https://conductscience.org/library/papers/27073531PubMed
1112800196Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.Int J Cancer2003https://conductscience.org/library/papers/12800196PubMed
1228764784E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.World J Surg Oncol2017https://conductscience.org/library/papers/28764784PubMed
1319294736Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.J Pathol2009https://conductscience.org/library/papers/19294736PubMed
1437833450The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).Breast Cancer Res Treat2024https://conductscience.org/library/papers/37833450PubMed
1535348974Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers.Breast Cancer Res Treat2022https://conductscience.org/library/papers/35348974PubMed
1631239068Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.Semin Oncol2019https://conductscience.org/library/papers/31239068PubMed
1731781079The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans.Front Microbiol2019https://conductscience.org/library/papers/31781079PubMed
1821104290Modulation of E-cadherin function and dysfunction by N-glycosylation.Cell Mol Life Sci2011https://conductscience.org/library/papers/21104290PubMed
1922659456Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments.Cancer Res2012https://conductscience.org/library/papers/22659456PubMed
2036239760Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer.J Natl Cancer Inst2022https://conductscience.org/library/papers/36239760PubMed

See all 90 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42352496Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges.Cancers (Basel)2026https://conductscience.org/library/papers/42352496PubMed
41751248The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms.Biomedicines2026https://conductscience.org/library/papers/41751248PubMed
41049266Breast Cancer: Molecular Pathogenesis and Targeted Therapy.MedComm (2020)2025https://conductscience.org/library/papers/41049266PubMed
40911019NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS).Histopathology2025https://conductscience.org/library/papers/40911019PubMed
39549221Comprehensive characterization of invasive mammary carcinoma with lobular features: integrating morphology and E-cadherin immunohistochemistry patterns.Breast Cancer2025https://conductscience.org/library/papers/39549221PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39138705

GET https://conductscience.org/api/papers/v1/39138705/references?page=2